WallStSmart

CME Group Inc (CME)vsMSCI Inc (MSCI)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

CME Group Inc generates 103% more annual revenue ($6.96B vs $3.43B). CME leads profitability with a 63.5% profit margin vs 40.3%. MSCI appears more attractively valued with a PEG of 1.84. CME earns a higher WallStSmart Score of 63/100 (C+).

CME

Buy

63

out of 100

Grade: C+

Growth: 6.7Profit: 8.0Value: 4.3Quality: 4.5
Piotroski: 1/9Altman Z: -0.67

MSCI

Buy

58

out of 100

Grade: C

Growth: 6.7Profit: 8.5Value: 4.3Quality: 7.0
Piotroski: 6/9Altman Z: 2.83

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CME4 strengths · Avg: 9.5/10
Profit MarginProfitability
63.5%10/10

Keeps 64 of every $100 in revenue as profit

Operating MarginProfitability
65.8%10/10

Strong operational efficiency at 65.8%

Market CapQuality
$108.50B9/10

Large-cap with strong market position

Debt/EquityHealth
0.139/10

Conservative balance sheet, low leverage

MSCI3 strengths · Avg: 10.0/10
Profit MarginProfitability
40.3%10/10

Keeps 40 of every $100 in revenue as profit

Operating MarginProfitability
56.4%10/10

Strong operational efficiency at 56.4%

Debt/EquityHealth
-2.2810/10

Conservative balance sheet, low leverage

Areas to Watch

CME3 concerns · Avg: 2.3/10
Piotroski F-ScoreQuality
1/93/10

Weak financial health signals

PEG RatioValuation
4.182/10

Expensive relative to growth rate

Altman Z-ScoreHealth
-0.672/10

Distress zone — elevated risk

MSCI3 concerns · Avg: 3.7/10
PEG RatioValuation
1.844/10

Expensive relative to growth rate

P/E RatioValuation
32.0x4/10

Premium valuation, high expectations priced in

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : CME

The strongest argument for CME centers on Profit Margin, Operating Margin, Market Cap. Profitability is solid with margins at 63.5% and operating margin at 65.8%. Revenue growth of 13.0% demonstrates continued momentum.

Bull Case : MSCI

The strongest argument for MSCI centers on Profit Margin, Operating Margin, Debt/Equity. Profitability is solid with margins at 40.3% and operating margin at 56.4%. Revenue growth of 12.4% demonstrates continued momentum.

Bear Case : CME

The primary concerns for CME are Piotroski F-Score, PEG Ratio, Altman Z-Score.

Bear Case : MSCI

The primary concerns for MSCI are PEG Ratio, P/E Ratio, Return on Equity.

Key Dynamics to Monitor

MSCI carries more volatility with a beta of 1.24 — expect wider price swings.

CME is growing revenue faster at 13.0% — sustainability is the question.

Monitor FINANCIAL DATA & STOCK EXCHANGES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CME scores higher overall (63/100 vs 58/100), backed by strong 63.5% margins and 13.0% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

CME Group Inc

FINANCIAL SERVICES · FINANCIAL DATA & STOCK EXCHANGES · USA

CME Group Inc. (Chicago Mercantile Exchange, Chicago Board of Trade, New York Mercantile Exchange, The Commodity Exchange) is an American global markets company. It is the world's largest financial derivatives exchange, and trades in asset classes that include agricultural products, currencies, energy, interest rates, metals, stock indexes and cryptocurrencies futures.

Visit Website →

MSCI Inc

FINANCIAL SERVICES · FINANCIAL DATA & STOCK EXCHANGES · USA

MSCI Inc. (formerly Morgan Stanley Capital International and MSCI Barra), is an American finance company headquartered in New York City and serving as a global provider of equity, fixed income, hedge fund stock market indexes, multi-asset portfolio analysis tools and ESG products. It publishes the MSCI BRIC, MSCI World and MSCI EAFE Indexes.

Visit Website →

Want to dig deeper into these stocks?